# Vijaya Diagnostic Centre (NSE: VIJAYA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/VIJAYA · Pivot · prices to 22 Oct 2026

Vijaya Diagnostic Centre (NSE: VIJAYA) closed at ₹1,382.60 on 22 Oct 2026, up 2.04% on the day. With a market capitalisation of ₹14,324 Cr, it ranks 445th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Diagnostics & Research.

At its last close the stock traded at 82.5× trailing earnings, against a return on equity of 18.1% in FY26. Over the past year the share price has risen 42.1%. Its 52-week range is ₹848.00 (30 Mar 2026) to ₹1,593.60 (23 Sep 2026); the last close is 13.2% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹231 Cr (+22.8% year on year) and net profit ₹53 Cr (+37.6%), on a consolidated basis. Promoters held 52.47% of the company as of 30 Jun 2026; 1.96% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹1,382.60 |
| Market cap | ₹14,324 Cr |
| P/E (trailing) | 82.5 |
| ROE | 18.1% (FY26) |
| ROCE | 19.2% (FY26) |
| Debt to equity | 0 |
| 52-week high | ₹1,593.60 (23 Sep 2026) |
| 52-week low | ₹848.00 (30 Mar 2026) |
| 1-year return | +42.1% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹231 Cr | +22.8% | ₹53 Cr | +37.6% | ₹5.16 |
| Q4 FY26 | ₹219 Cr | +26.6% | ₹48 Cr | +37.5% | ₹4.66 |
| Q3 FY26 | ₹205 Cr | +21.4% | ₹43 Cr | +22.3% | ₹4.20 |
| Q2 FY26 | ₹202 Cr | +10.2% | ₹43 Cr | +2.8% | ₹4.21 |
| Q1 FY26 | ₹188 Cr | +20.4% | ₹39 Cr | +22.5% | ₹3.76 |
| Q4 FY25 | ₹173 Cr | +11.6% | ₹35 Cr | +3.5% | ₹3.38 |
| Q3 FY25 | ₹169 Cr | +27.3% | ₹35 Cr | +35.8% | ₹3.42 |
| Q2 FY25 | ₹183 Cr | +31.8% | ₹42 Cr | +25.5% | ₹4.09 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹681 Cr | ₹144 Cr |
| FY24 | ₹548 Cr | ₹120 Cr |
| FY23 | ₹459 Cr | ₹85 Cr |
| FY22 | ₹462 Cr | ₹111 Cr |
| FY21 | ₹377 Cr | ₹85 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 52.47%
- Foreign institutions: 11.65%
- Domestic institutions: 31.58%
- Non-institutions: 4.31%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Syngene International](https://app.pivotnow.in/stock/SYNGENE) | ₹370.75 | ₹15,037 Cr | 47 | 6.5% |
| [Dr. Agarwal's Health Care](https://app.pivotnow.in/stock/AGARWALEYE) | ₹459.10 | ₹14,852 Cr | 100 | 6.6% |
| [Jubilant Pharmova](https://app.pivotnow.in/stock/JUBLPHARMA) | ₹930.80 | ₹14,848 Cr | 37.1 | 13.4% |
| [Poly Medicure](https://app.pivotnow.in/stock/POLYMED) | ₹1,479.10 | ₹14,686 Cr | 46.7 | 10.4% |
| [Indegene](https://app.pivotnow.in/stock/INDGN) | ₹577.95 | ₹14,171 Cr | 34.8 | 12.8% |
| [Natco Pharma](https://app.pivotnow.in/stock/NATCOPHARM) | ₹785.00 | ₹14,063 Cr | 9.9 | 15.4% |

## Questions and answers

### What is the share price of Vijaya Diagnostic Centre today?

Vijaya Diagnostic Centre (NSE: VIJAYA) last closed at ₹1,382.60 on 22 Oct 2026. Its 52-week high is ₹1,593.60 and its 52-week low is ₹848.00.

### What is the market cap of Vijaya Diagnostic Centre?

Vijaya Diagnostic Centre's market capitalisation is ₹14,324 Cr (₹14,324 Cr) at the 22 Oct 2026 close, ranking 445th among the NSE companies Pivot tracks.

### What is the P/E ratio of Vijaya Diagnostic Centre?

Vijaya Diagnostic Centre trades at a trailing P/E of 82.5. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 46.7.

### What is the ROE and ROCE of Vijaya Diagnostic Centre?

Return on equity was 18.1% in FY26 and return on capital employed was 19.2% in FY26 (consolidated figures).

### Is Vijaya Diagnostic Centre a debt-free company?

Vijaya Diagnostic Centre is close to debt-free: its debt-to-equity ratio was 0 in FY26.

### What were Vijaya Diagnostic Centre's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Vijaya Diagnostic Centre reported revenue of ₹231 Cr, +22.8% year on year, and net profit of ₹53 Cr, +37.6% year on year.

### How has Vijaya Diagnostic Centre stock performed over the last year?

Vijaya Diagnostic Centre's share price has risen 42.1% over the past year, +5.5% over three months and −10.6% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Vijaya Diagnostic Centre?

As of 30 Jun 2026: promoters 52.47%, foreign institutions 11.65%, domestic institutions 31.58%, non-institutions 4.31%. 1.96% of promoter shares were pledged.

### Who are Vijaya Diagnostic Centre's competitors?

The listed Pharma & Healthcare companies closest to Vijaya Diagnostic Centre by market cap are Syngene International, Dr. Agarwal's Health Care, Jubilant Pharmova, Poly Medicure, Indegene and Natco Pharma.

### Is Vijaya Diagnostic Centre a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Vijaya Diagnostic Centre's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on VIJAYA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.